Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for CLRD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2023 -44.54M
June 30, 2023 -42.12M
March 31, 2023 -38.41M
December 31, 2022 -43.10M
September 30, 2022 -36.32M
June 30, 2022 -37.07M
March 31, 2022 -34.74M
December 31, 2021 -31.27M
September 30, 2021 -27.54M
June 30, 2021 1.69M
March 31, 2021 2.256M
December 31, 2020 -16.63M
September 30, 2020 3.218M
June 30, 2020 2.20M
March 31, 2020 1.833M
December 31, 2019 1.503M
September 30, 2019 0.935M
June 30, 2019 3.287M
March 31, 2019 4.434M
December 31, 2018 6.745M
September 30, 2018 8.967M
June 30, 2018 3.142M
March 31, 2018 4.651M
December 31, 2017 5.112M
September 30, 2017 6.924M
Date Value
June 30, 2017 9.329M
March 31, 2017 11.57M
December 31, 2016 14.10M
September 30, 2016 7.216M
June 30, 2016 7.933M
March 31, 2016 10.75M
December 31, 2015 13.12M
September 30, 2015 6.37M
June 30, 2015 8.209M
March 31, 2015 10.09M
December 31, 2014 4.002M
September 30, 2014 6.502M
June 30, 2014 8.423M
March 31, 2014 8.309M
December 31, 2013 7.306M
September 30, 2013 11.11M
June 30, 2013 7.689M
March 31, 2013 8.05M
December 31, 2012 10.29M
September 30, 2012 9.792M
June 30, 2012 11.86M
March 31, 2012 15.00M
December 31, 2011 11.18M
September 30, 2011 13.97M
June 30, 2011 16.89M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
The Cigna Group 42.62B
Centene Corp. 22.56B
CorVel Corp. 408.89M
CVS Health Corp. 79.70B
Humana, Inc. 19.21B